Ocular Therapeutix
OCUL
#4646
Rank
NZ$3.48 B
Marketcap
NZ$16.37
Share price
-3.21%
Change (1 day)
18.28%
Change (1 year)

Earnings for Ocular Therapeutix (OCUL)

Earnings in 2025 (TTM): -NZ$0.43 Billion

According to Ocular Therapeutix's latest financial reports the company's current earnings are NZ$55.78 Million. In 2024 the company made an earning of -NZ$0.32 Billion a decrease over its 2023 earnings that were of -NZ$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ocular Therapeutix from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.43 Billion35.03%
2024 -NZ$0.32 Billion139.68%
2023 -NZ$0.14 Billion13.65%
2022 -NZ$0.12 Billion984.05%
2021 -NZ$10.79 Million-95.79%
2020 -NZ$0.26 Billion80.19%
2019 -NZ$0.15 Billion44.01%
2018 -NZ$98.67 Million-5.38%
2017 -NZ$0.11 Billion41.79%
2016 -NZ$73.55 Million12.47%
2015 -NZ$65.39 Million38.75%
2014 -NZ$47.13 Million115.12%
2013 -NZ$21.91 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
SurModics
SRDX
-NZ$18.44 Million-95.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Anika Therapeutics
ANIK
NZ$21.41 M-105.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Intersect ENT
XENT
-NZ$0.27 Billion-35.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
NZ$0.39 B-197.22%๐Ÿ‡บ๐Ÿ‡ธ USA